DAMORA THERAPEUTICS, INC. (DMRA)

SEC filing

DAMORA THERAPEUTICS, INC.

DMRA · CIK 1800315

4 · Jan 6, 2026 · Schambye Hans T. sold 700 shares at $21.38/share ($14,966); exercised options for 1,360 shares

Schambye Hans T. sold 700 shares at $21.38/share ($14,966); exercised options for 1,360 shares

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).